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Abstract
Background: Newly delivered herpes simplex virus genomes are subject to repression during the
early stages of infection of human fibroblasts. This host defence strategy can limit virus replication
and lead to long-term persistence of quiescent viral genomes. The viral immediate-early protein
ICP0 acts to negate this negative regulation, thereby facilitating the onset of the viral replication
cycle. Although few mechanistic details are available, the host repression machinery has been
proposed to assemble the viral genome into a globally inaccessible configuration analogous to
heterochromatin, blocking access to most or all trans-acting factors. The strongest evidence for
this hypothesis is that ICP0-deficient virus is unable to reactivate quiescent viral genomes, despite
its ability to undergo productive infection given a sufficiently high multiplicity of infection. However,
recent studies have shown that quiescent infection induces a potent antiviral state, and that ICP0
plays a key role in disarming such host antiviral responses. These findings raise the possibility that
cells containing quiescent viral genomes may be refractory to superinfection by ICP0-deficient
virus, potentially providing an alternative explanation for the inability of such viruses to trigger
reactivation. We therefore asked if ICP0-deficient virus is capable of replicating in cells that contain
quiescent viral genomes.
Results: We found that ICP0-deficient herpes simplex virus is able to infect quiescently infected
cells, leading to expression and replication of the superinfecting viral genome. Despite this
productive infection, the resident quiescent viral genome was neither expressed nor replicated,
unless ICP0 was provided in trans.
Conclusion: These data document that quiescent HSV genomes fail to respond to the virally
modified host transcriptional apparatus or viral DNA replication machinery provided in trans by
productive HSV infection in the absence of ICP0. These results point to global repression as the
basis for HSV genome quiescence, and indicate that ICP0 induces reactivation by overcoming this
global barrier to the access of trans-acting factors.
Background
Herpes simplex virus (HSV) is a significant human patho-
gen and the prototypical member of the herpesviridae, a
large family of enveloped nuclear DNA viruses. HSV dis-
plays two modes of interaction with its human host: lytic
and latent (reviewed in [1]). Primary infection of epithe-
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lial cells produces the lytic response – productive virus
replication followed by cell death. Progeny virions then
infect adjacent sensory neurons, establishing a life-long
latent interaction. Productive infection is characterized by
the sequential expression of three classes of viral genes,
immediate-early (IE), early (E) and late (L). This regula-
tory cascade is initiated by VP16, an abundant tegument
protein that activates transcription of the IE genes. Four of
the IE proteins (ICP0, ICP4, ICP22 and ICP27) then serve
to drive further progression into the lytic program. Three
of these, ICP4, ICP22 and ICP27, contribute in various
ways to the activation of the E and/or L genes [1]. The role
of ICP0 appears to be distinct, in that it is also required for
efficient IE gene expression [2-4]. Thus, ICP0 mutant
viruses display reduced levels of IE gene expression during
infection [3-5], and ICP0 activates expression of IE, E and
L genes in transient transfection assays [6-10]. Moreover,
expression of ICP0 in trans substantially complements the
defect of VP16 mutants [11,12], which are otherwise
arrested prior to the IE phase following low multiplicity
infection. The function of ICP0 therefore seems to lie
upstream of those of the other IE gene products in the
HSV regulatory cascade.
ICP0 has been described as a promiscuous activator capa-
ble of stimulating the expression of a wide range of viral
and cellular promoters in transient co-transfection assays
(reviewed in [13]). It acts to enhance mRNA accumula-
tion, at least in part by stimulating transcription [14,15].
However it does not bind DNA and there is no evidence
that it acts directly on the transcriptional apparatus.
Rather, ICP0 appears to stimulate HSV gene expression at
least in part by counteracting one or more cellular repres-
sion mechanisms that otherwise silence newly delivered
viral genomes (reviewed in [16]). This hypothesis
emerged from the finding that viral genomes unable to
express ICP0 often fail to engage the viral lytic program of
gene expression and instead persist for extended periods
in the nucleus in an extrachromosomal non-linear config-
uration without giving rise to appreciable levels of viral
gene products [17-21]. Such quiescent genomes however
remain potentially functional, as they can be efficiently
reactivated by superinfecting the cultures with HSV or
human cytomegalovirus (HCMV, another herpesvirus) or
by providing ICP0 or HCMV pp71 in trans [17-19,22-24].
The IE promoters residing in quiescent HSV genomes
appear to be repressed rather than simply inactive, as they
fail to respond to VP16 and several other stimuli that oth-
erwise augment their activity [18]; however, they remain
susceptible to activation by ICP0 or pp71 [18,23]. Repres-
sion of genomes entering quiescence occurs gradually:
newly delivered IE promoters are initially responsive to
VP16 and other stimuli and are only later rendered refrac-
tory to stimuli other than ICP0 [18]. Perhaps unexpect-
edly, the otherwise constitutively active HCMV IE
promoter is also repressed as recombinant HSV genomes
enter quiescence [18-20]. Taken in combination, these
data suggest that newly delivered HSV and HCMV IE pro-
moters are targeted by a cellular repression mechanism
that is inactivated by ICP0. HSV E and L promoters are
also inactive during quiescence; however it is not yet clear
if they are actively repressed like the IE promoters or sim-
ply inactive due to the absence of the IE proteins.
The mechanisms underlying repression and reactivation
of quiescent HSV genomes remain unclear. ICP0 interacts
with numerous cellular proteins (reviewed in [25])
including some that could plausibly contribute to gene
silencing (for example, type II histone deacetylases [26]
and the coREST/REST repressor complex [27]). In addi-
tion, ICP0 bears a RING-finger E3 ubiquitin ligase
domain [28-30] that is essential for reactivation [24], sug-
gesting that it may act at least in part by targeting key com-
ponents of the cellular repression machinery for
ubiquitination and degradation. Consistent with this
view, reactivation is blocked by proteasome inhibitors
[24]. However, the crucial target(s) of ICP0 relevant to
reactivation have yet to be defined. It may be significant
that infecting HSV genomes initially localize to the
periphery of nuclear ND10 domains [31-33], and that
ICP0 disrupts ND10 [34-36] by targeting several compo-
nents, including PML, for destruction [37-39]. However,
the intranuclear location of quiescent genomes has yet to
be determined, and current evidence suggests that tran-
scriptional activity is required for the association of viral
genomes with ND10 [33]. Thus, it is not clear what, if any,
role ND10 play in quiescence.
A remarkable feature of quiescent HSV genomes is that
they fail to detectably respond to superinfection with
ICP0-deficient HSV [22,40-42]. The result is striking
because ICP0-deficient HSV is itself capable of produc-
tively infecting many cell types including those used to
establish quiescence, giving rise to infectious progeny.
One interpretation of these data is that quiescent HSV
genomes are inaccessible to the virally modified transcrip-
tional apparatus and HSV DNA replication machinery
provided  in trans by the superinfecting virus in the
absence of ICP0 [16,41]. If this interpretation is correct,
then it follows that: (1) quiescence involves a global
restriction in the accessibility of the viral genome to trans-
acting factors perhaps akin to that associated with the het-
erochromatinization of silent host chromosomal loci, and
(2) ICP0 induces reactivation by overcoming this general-
ized barrier to genome activity. However, another hypoth-
esis to explain the inability of ICP0-deficient viruses to
induce reactivation is that ICP0 may be required for pro-
ductive infection of cells harboring quiescent HSV. Under
this alternative scenario, ICP0-deficient HSV is effectively
excluded from the cells harboring the resident virus,Virology Journal 2005, 2:85 http://www.virologyj.com/content/2/1/85
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thereby precluding genome reactivation. This "superinfec-
tion-immunity" model has not been examined in previ-
ous studies; however several considerations suggest that it
should be carefully evaluated. First, the severity of the
phenotype of ICP0-deficient mutants varies markedly
between cell types [43] and during cell cycle progression
[44], raising the possibility that such mutants may be unu-
sually sensitive to any perturbations of cellular physiology
induced by quiescent HSV infection. Second, the data of
Hobbs et al [22] indicate that the replication of ICP0-defi-
cient HSV is severely compromised under the conditions
used by those authors in their reactivation assays. Third,
HSV virions trigger the induction of a potent antiviral state
associated with activation of a subset of IFN-inducible
genes in human fibroblasts under conditions where viral
gene expression is prevented [45-48], as in quiescence.
Moreover, ICP0 serves to block this cellular antiviral
response [48], by preventing the activation of IRF3
through unknown mechanisms [49]. Consistent with this
particular mechanism of superinfection immunity, ICP0
mutants are hypersensitive to the antiviral effects of type I
IFN [50-52] and thus might also be expected to be unusu-
ally sensitive to the IFN-independent antiviral state pro-
voked by HSV virions. Fourth, it is possible that quiescent
HSV itself gives rise to one or more gene products that
interfere with replication of superinfecting ICP0-deficient
HSV in a fashion analogous to the repressors produced by
temperate bacteriophages.
Considering the foregoing, we examined the susceptibility
of human embryonic lung (HEL) fibroblasts harboring
quiescent HSV-1 genomes to productive superinfection by
ICP0-deficient HSV. We found that such cells are capable
of supporting expression and replication of superinfecting
ICP0-deficient genomes, given a sufficiently high input
multiplicity of infection (MOI). However, the resident
quiescent viral genomes were not detectably expressed or
replicated in these superinfected cultures. Our results
therefore rule out the superinfection-immunity model for
the inability of ICP0-deficient HSV to reactivate quiescent
HSV, and document that quiescent HSV genomes fail to
respond to the virally modified host transcriptional appa-
ratus or viral DNA replication machinery during produc-
tive HSV infection in the absence of ICP0. These results
point to global repression as the basis for HSV genome
quiescence, and indicate that ICP0 induces reactivation by
overcoming this global barrier to trans-acting factors.
Results and Discussion
ICP0 is specifically required for reactivation of gene 
expression from quiescent HSV-1 KM110-R genomes
We first confirmed that ICP0 is required for reactivation in
a model of HSV genome quiescence previously developed
in our laboratory. The HSV-1 KOS isolate KM110 bears
mutations that inactivate the transactivation functions of
VP16 and ICP0, severely inhibiting IE gene expression
[53]. KM110 fails to enter the lytic cycle following high
multiplicity infection of human embryonic lung (HEL)
fibroblasts; instead, the infected cell monolayer survives
and the KM110 genome persists in a quiescent and reacti-
vation-competent state for at least 10 days [53]. In the
present study we used a marked derivative of KM110
(KM110-R) bearing a transgene consisting of red fluores-
cent protein coding sequences (DsRed2) driven from the
human cytomegalovirus IE promoter inserted at the thy-
midine kinase locus (Methods) in order to facilitate detec-
tion of reactivation of KM110 in individual cells.
Monolayers of HEL cells were infected with 2 PFU/cell
KM110-R to establish quiescence. Four days later the cul-
tures were mock infected or infected with 10 PFU/cell of
wild-type HSV-1 KOS or viral mutants bearing lesions in
various IE genes. Cells were harvested 24 hours later, then
scored for reactivation of the RFP transgene carried by
KM110-R by flow cytometry (figure 1). Only 1% of mock-
superinfected cells detectably expressed the RFP trans-
gene; in contrast, ca. 28% of cells expressed RFP following
superinfection with wild-type HSV-1 KOS. These data
indicate that at least a subset of cells in the culture con-
tained reactivation-competent KM110-R genomes and
confirm previous reports that expression driven from the
HCMV promoter is inhibited during HSV quiescence [18-
20]. KM110-R cannot spread to neighboring cells follow-
ing reactivation with wild-type KOS under the conditions
used in this experiment because all cells in the monolayer
were productively infected with a high multiplicity of KOS
at the outset of the reactivation process therefore exclud-
ing superinfecting HSV ([54-56] and data not shown). The
data presented in figure 1 therefore indicate that a mini-
mum of ca. 27% of the cells in the monolayer harbored
silent but reactivation-competent KM110-R. This value
may underestimate the true proportion of quiescently
infected cells as dsRed2 folds into the mature fluorescent
form quite slowly (CLONTECHniques XVI:3, 2001; Clon-
tech, Palo Alto, Calif.), raising the possibility that some
reactivation events may be missed. Reactivation was also
observed following super-infection with HSV mutants
lacking functional ICP4 (d120), ICP22 (d22-lacZ), and
ICP27 (d27-1), confirming that none of these proteins
plays an essential role in the reactivation process. We con-
sistently found that the proportion of cells expressing RFP
was significantly higher following superinfection with
d120 than with any of the other virus isolates tested. Inas-
much as d120 is less effective at excluding super-infecting
HSV than any of the other viruses examined (data not
shown), it is possible that some or all of this increase
stems from spread of reactivated KM110-R to neighboring
cells over the course of the reactivation assay. Alterna-
tively, overproduction of ICP0 and other IE proteins dur-
ing d120 infection may lead to a greater reactivation
frequency. In striking contrast to the other viral isolates,Virology Journal 2005, 2:85 http://www.virologyj.com/content/2/1/85
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ICP0 is required for reactivation of the HCMV IE promoter in quiescent HSV genomes Figure 1
ICP0 is required for reactivation of the HCMV IE promoter in quiescent HSV genomes. Confluent monolayers of 
HEL cells were infected with 2 PFU/cell of KM110-R in order to establish a quiescent infection. Four days later the cells were 
mock infected or superinfected with wild-type HSV-1 KOS or the indicated IE mutant at an MOI of 10. Samples were har-
vested 24 hours later and analyzed by flow cytometry. The results are presented as a scatter plot in which the fluorescence in 
the red and green channels are plotted for each cell analyzed. Values in each panel report the fraction of cells that were scored 
as positive for RFP expression (indicated as red dots).
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the ICP0 mutant n212 failed to detectably induce RFP
expression from quiescent KM110-R. These data confirm
that ICP0 is required for reactivation of gene expression
driven from the HCMV IE promoter located in quiescent
HSV-1 genomes, in accordance with previous reports.
We next asked if ICP0 is also required to reactivate expres-
sion of the E/L HSV gene encoding VP16. VP16 arising
from the KM110-R genome can be readily distinguished
from that produced by the superinfecting viruses because
KM110-R bears a linker insertion mutation (V422) that
truncates VP16 after amino acid residue 422, altering its
electrophoretic mobility [53]. To test the requirements for
reactivation of VP16 expression, monolayers containing
or lacking quiescent KM110-R (input MOI of 6) were
superinfected with the same panel of HSV-1 isolates as
before, then analyzed by Western blot using a VP16 mon-
oclonal antibody (figure 2A). As expected on the basis of
previous work [53], wild-type HSV-1 KOS efficiently reac-
tivated VP16 expression from the resident KM110-R
genome, as did d120 (ICP4-), d22-lacZ (ICP22-) and d27-
1 (ICP27-). In contrast, the ICP0-deficient mutant n212
failed to detectably reactivate VP16 expression. The phe-
notype displayed by n212 was distinct from that exhibited
by the other IE mutants in that the VP16 gene residing in
the superinfecting n212 genome was efficiently expressed
while the corresponding gene of KM110-R remained
silent. By contrast, both versions of VP16 were efficiently
expressed following superinfection with all of the other
viruses, including the ICP4-deficient mutant d120,
despite the fact that ICP4 is stringently required for expres-
sion of VP16 and other HSV E and L genes [57,58]. Pre-
sumably, the requisite ICP4 is provided in trans by the
reactivated KM110-R. Indeed, as expected, d120 failed to
express VP16 following infection of control HEL cells
lacking KM110-R. Taken in combination, these data dem-
onstrate that ICP0 is required for reactivation of VP16
expression from the quiescent genome.
ICP0 is required for reactivation of viral DNA replication
Previous work has implied that ICP0 is required for repli-
cation of the resident viral genome following superinfec-
tion of cells harboring quiescent HSV [40,41]. To
determine if this is the case in our system, we used South-
ern blot hybridization to monitor replication of the resi-
dent KM110-R genome following superinfection with
wild-type and mutant virus (figure 2B). The genome of
KM110-R can be readily distinguished from that of wild-
type HSV-1 because it bears an NheI linker at the VP16
locus that marks the V422 mutation [59]. As a result, the
8.1 kb BamHI fragment that spans the VP16 locus is
cleaved by NheI in KM110-R, yielding fragments of 4.9
and 3.2 kb (figure 2B). Quiescent KM110-R genomes were
not detectable prior to reactivation under the conditions
used in our Southern blot assay; however the expected
KM110-R signal was readily detected following genome
amplification induced by super-infection with wild-type
KOS (figure 2B). Mutants lacking ICP4, ICP22, and ICP27
(d120, d22-lacZ and d27-1 respectively) triggered replica-
tion of the KM110-R genome as effectively as wild-type
KOS; in contrast, no amplified KM110-R signal was
observed following infection with the ICP0-deficient
mutant n212. As expected [1], the ICP4 and ICP27 null
mutants each displayed a severe DNA replication defect in
cells lacking KM1110-R. These defects were however com-
plemented in cells harboring KM110-R, presumably due
to provision of the missing gene products in trans from
the reactivated KM110-R genome.
Taken in combination, the data presented above clearly
document that ICP0 is essential for the reactivation of
expression from the HCMV IE and HSV VP16 promoters
and replication of quiescent HSV-1 genomes in superin-
fected cultures, confirming and extending the results of
previous studies.
ICP0-deficient HSV-1 is able to infect cells that harbor 
quiescent KM110-R
We next sought to determine if ICP0-deficient HSV is able
to productively infect cells that contain quiescent KM110-
R. Previous work has documented that the magnitude of
the defect exhibited by ICP0-deficient HSV varies with cell
type and is particularly pronounced on HEL cells [43].
Consistent with these findings, preliminary experiments
indicated that only ca. 45% of HEL cells proceeded to the
stage of viral DNA replication following infection with 10
PFU/cell n212, compared to >95% following infection
with 10 PFU/cell of KOS (data not shown). However, this
proportion could be increased to ca. 90% when the MOI
of n212 was raised to 30 PFU/cell (figure 6 and additional
data not shown). Therefore, in order to maximize the pro-
portion of cells productively infected by ICP0-deficient
HSV, all of the remaining reactivation experiments
described in this report employed an MOI of 30 for n212
and 10 for wild-type KOS. Importantly, n212 was unable
to reactivate quiescent KM110-R in any of our assays fol-
lowing infection at this higher MOI (see below).
To determine if ICP0-deficient HSV is able to initiate gene
expression in HEL cells containing quiescent virus, cul-
tures were superinfected with a marked n212 derivative
(n212-G) bearing an eGFP transgene driven from the
HCMV IE promoter inserted at the thymidine kinase
locus; an analogous derivative of KOS (KOS-G) served as
a control. Replicate monolayers harboring quiescent
KM110-R (input MOI, 6 PFU/cell) were superinfected
with these indicator viruses on day four, then analyzed for
transgene expression by flow cytometery 18 hours later
(figure 3). For technical reasons RFP expression from reac-
tivated KM110-R cannot be reliably assessed by flowVirology Journal 2005, 2:85 http://www.virologyj.com/content/2/1/85
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cytometry in HEL cells that also express GFP (see Meth-
ods). Therefore, the proportion of cells harboring reactiva-
tion-competent KM110-R was estimated by
superinfecting parallel cultures with unmarked KOS and
n212 (MOIs of 10 and 30 respectively). As before, mock-
superinfected cultures displayed a relatively low propor-
tion of cells expressing RFP (average of 6.5% in four exper-
iments using an MOI of KM110-R of 6), while
superinfection with wild-type HSV-1 KOS increased this
value to ca. 45% (figure 3). Thus, at minimum, ca. 40% of
the cells harbored quiescent but reactivation-competent
KM110-R at the time of superinfection. Consistent with
previous experiments, n212 at an MOI of 30 did not
increase the proportion of RFP-positive cells beyond that
observed in mock-infected cultures (figure 3), or reacti-
vate VP16 expression from KM110-R (figure 4). However,
n212-G was able to infect >95% of the cells in the cultures
as judged by eGFP expression, a value similar to that
obtained with KOS-G (figure 3). These data therefore indi-
cate that ICP0-deficient HSV-1 is able to initiate viral gene
expression in essentially every cell that harbors quiescent
KM110-R.
Previous studies have shown that ICP0-deficient HSV-1
often stalls at varied points in the viral gene expression
program subsequent to the immediate-early phase [3,43].
Therefore, expression of eGFP from the HCMV IE pro-
moter does not necessarily imply productive infection
with n212-G. As one measure of the ability of ICP0-defi-
cient HSV to progress to later stages of infection, we scored
the superinfected cells for the presence of viral DNA repli-
cation compartments in parallel experiments. Quiescently
infected HEL cells grown on coverslips were mock-treated
or superinfected with KOS or n212 (MOIs of 10 and 30
respectively) in the presence or absence of 400 µg/mL
phosphonoacetic acid (PAA) to block viral DNA replica-
tion; replication compartments were then visualized 9.5
hours later by examining the intranuclear distribution of
the immediate-early protein ICP4 by indirect immunoflu-
orescence (figure 5). Previous work has shown that ICP4
is initially recruited to small nuclear foci termed pre-repli-
cative sites at early times post-infection; pre-replicative
sites then develop into much larger ICP4-positive DNA
replication compartments that fill much of the nucleus at
late times post-infection in a process requiring viral DNA
replication [60]. As expected, only a very small fraction
(2%) of cells in KM110-R infected monolayers expressed
ICP4 in the absence of superinfection. The ICP4 staining
in these "background" positive cells illuminated large rep-
lication compartments that filled most of the nuclear vol-
ume (figure 5). Presumably, this signal marks cells that are
undergoing productive infection by KM110-R. In contrast,
the great majority of cells (>90%) in the KM110-R
infected cultures expressed ICP4 following superinfection
with KOS or n212, irrespective of the presence or absence
of PAA (see figure 5 for data obtained with n212). These
results document that both KOS and n212 are able to ini-
tiate HSV IE gene expression in the majority of cells in the
quiescently infected cultures. As expected, the ICP4 stain-
ing pattern in superinfected cells was highly dependent on
the presence or absence of PAA (figure 5). The signal in
the presence of PAA was diffuse with many small discrete
foci of staining in some cells; in contrast, large ICP4-posi-
tive structures (replication compartments) that filled
much of the nucleus were observed in most cells main-
tained in the absence of PAA (figure 5). The proportion of
cells displaying replication compartments was quantified
in three experiments and the data obtained are summa-
ICP0 is required for reactivation of VP16 gene expression  and viral DNA replication Figure 2
ICP0 is required for reactivation of VP16 gene 
expression and viral DNA replication. Confluent mon-
olayers of HEL cells were infected with 6 PFU/cell of KM110-
R to establish quiescence. Four days later the cells were 
mock infected or superinfected with the indicated HSV 
strains (MOI of 10). Samples harvested 18 hours later were 
then analyzed for VP16 expression by Western Blot (panel 
A) or viral DNA replication by Southern blot (panel B). (A) 
Samples were scored for VP16 and cellular β-actin by West-
ern blot. (B) Total cellular DNA was cleaved with Bam HI 
and Nhe I, then analyzed by Southern blot hybridization using 
an HSV-1 VP16 probe. U2OS cells: samples extracted from 
permissive U2OS 24 hours after infection infected with 
KM110-R (MOI of 10). wt: wild-type VP16 protein or gene; 
mt: mutant VP16 protein or gene.
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ICP0-deficient HSV is able to initiate infection in cells harbouring quiescent KM110-R Figure 3
ICP0-deficient HSV is able to initiate infection in cells harbouring quiescent KM110-R. Confluent monolayers of 
HEL cells were infected with 6 PFU/cell KM110-R. 4 days later the cells were mock treated or superinfected with n212 or 
n212-G (MOI 30), or KOS or KOS-G (MOI 10). Samples were harvested 18 hours later and analyzed by Flow cytometry. The 
intensity of red fluorescence is shown on the y-axis, and green fluorescence on the x-axis. The red and green dots indicate cells 
expressing RFP and GFP. The purple dots indicate cells that clearly expressed both proteins (however note that GFP expres-
sion interferes with the detection of RFP in most cells, see Methods). The proportion of cells scored as positive for expression 
of RFP (mock, n212, KOS) or GFP (KOS-G, n212-G) are indicated; values represent the average of four independent experi-
ments. Standard deviations were mock: 4%, n212: 3%, KOS: 4%, n212-G: 2%, KOS-G: 0%.
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rized in figure 6. Only 2% of the cells in cultures harbor-
ing quiescent KM110-R displayed viral DNA replication
compartments in the absence of superinfection (991 cells
scored in total over three experiments). In contrast, repli-
cation compartments formed in 97% +/- 2% of these cells
following superinfection with KOS (866 cells scored), a
value that did not differ from that observed following
KOS superinfection of cultures lacking quiescent KM110-
R (97% +/- 2%, 1069 cells scored). At the MOI of 30 used
in these experiments, n212 formed replication compart-
ments in 92% +/- 2% and 88% +/- 2% of cells in mock-
infected and KM110-R infected cultures (samples sizes of
1578 and 1661 cells respectively). Inasmuch as a mini-
mum of ca. 40% of the cells in the KM110-infected cul-
tures harbored silent but reactivation-competent KM110-
R at the time of superinfection (figure 3), these data dem-
onstrate that n212 is able to form DNA replication com-
partments in the majority of cells that contain quiescent
KM110-R. However, n212 (30 PFU/cell) did not detecta-
bly reactivate replication of the quiescent KM110-R
genome in parallel cultures (figure 4).
As another measure of the ability of the KM110-R genome
to replicate following superinfection, we asked if KM110-
R was recovered in the progeny virus thus produced. To
this end, progeny virus harvested 18 hours after superin-
fection was subjected to plaque assay in permissive U2OS
cells, and the titres of RFP-positive (KM110-R) and RFP-
negative virus were determined (table 1). KOS and n212
gave rise to approximately equivalent numbers of infec-
tious progeny, and the yields of both viruses were reduced
by approximately 50% on cultures harboring KM110-R
relative to mock-infected HEL cells. Thus replication of
n212 was not greatly impaired relative to wild-type HSV
under the conditions of this experiment. Approximately
25% of the progeny recovered following KOS superinfec-
tion expressed the RFP marker characteristic of KM110-R.
In contrast only ca. 0.06% of the progeny of the n212
infection bore the RFP marker, a reduction of ca. 3 orders
of magnitude relative to wild-type HSV. These data docu-
ment that ICP0 is required for efficient recovery of a
genetic marker carried by the quiescent genome into prog-
eny virus. Similar results have been reported previously
[22,40,41], however it was not clear from the data pre-
sented in those reports if the ICP0-deficient superinfecting
virus was competent to replicate in those cells that har-
bored quiescent HSV.
Summary and implications
Our results document that ICP0-deficient HSV is capable
of productively infecting cells that harbor quiescent HSV
genomes: given a sufficiently high multiplicity of infec-
tion the superinfecting virus initiates gene expression and
progresses to at least the stage of viral DNA replication in
the majority of such cells. Remarkably, this productive
infection does not provoke reactivation of the resident
viral genomes. These data exclude the superinfection-
immunity model for the failure of ICP0-deficient HSV to
trigger reactivation and provide strong support for the
ICP0-deficient HSV fails to reactivate VP16 expression or  viral DNA replication following high MOI infection Figure 4
ICP0-deficient HSV fails to reactivate VP16 expres-
sion or viral DNA replication following high MOI 
infection. Confluent monolayers of HEL cells were mock 
infected or infected with 6 PFU/cell of KM110-R to establish 
quiescence. Four days later the cells were mock infected or 
superinfected with 30 PFU/cell of n212 or 10 PFU/cell of 
KOS. Samples harvested 18 hours later were then analyzed 
for VP16 expression by Western Blot (panel A) or viral DNA 
replication by Southern blot (panel B). (A) Samples were 
scored for VP16 and cellular β-actin by Western blot. (B) 
Total cellular DNA was cleaved with Bam HI and Nhe I, then 
analyzed by Southern blot hybridization using an HSV-1 VP16 
probe. Lane U2OS cells: samples extracted from U2OS cells 
24 hours after infection with 10 PFU/cell KM110-R; Lanes 
KOS 1 hr and n212 1 hr: samples harvested from HEL cells 
one hour postinfection with KOS or n212 (MOIs of 10 and 
30 respectively), documenting that the input virus does not 
interfere with detection of newly synthesized VP16 or viral 
DNA. wt: wild-type; mt: mutant
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suggestion that quiescent HSV genomes are functionally
inaccessible to the modified transcription apparatus and
viral DNA replication factors provided by the superinfect-
ing virus [16,41]. As pointed out by Preston [16], the
refractory state of quiescent HSV genomes appears to be
distinct from that adopted by the viral genome during
latent infection of sensory neurons, as latent HSV
genomes can be reactivated in response to external signals
or by expression of any of HSV VP16, ICP4 or ICP0 [12];
in contrast, the only known means of reactivating quies-
cent genomes is via expression of ICP0 or its HCMV func-
tional counterpart pp71. The implication is that quiescent
genomes are more effectively shielded from trans-acting
factors than latent genomes.
The mechanisms that prevent quiescent HSV genomes
from responding to trans-acting factors are of great inter-
est, as is the mode of action of ICP0 in overcoming this
barrier to gene expression and DNA replication.
Sequence-specific repression seems unlikely, for two rea-
sons. First, the results of this and previous [18,41] reports
indicate that genes driven from at least three distinct cate-
gories of viral promoters (HCMV IE, HSV IE, and HSV
VP16) remain silent in cells superinfected with ICP0-defi-
cient HSV, despite the activity of the corresponding genes
located in the superinfecting viral genome. Similarly, the
quiescent genome fails to respond to the viral DNA repli-
cation and recombination machinery provided by the
superinfecting virus. These data suggest that the inhibitory
mechanism renders many (if not all) of the cis-acting ele-
ments (eg. promoters and origins of DNA replication)
located in the quiescent genome non-operative. Second,
the quiescent genome is not activated by replication of the
superinfecting viral genome within the same nucleus, a
condition that would likely titrate classical sequence-spe-
cific DNA-binding repressors. These data suggest that qui-
escent genomes may be stably associated with repressive
material that does not readily equilibrate between viral
genomes, or located at one or more inaccessible intranu-
clear sites.
ICP0-deficient HSV is able to form replication compartments  in cells harbouring quiescent KM110-R Figure 5
ICP0-deficient HSV is able to form replication com-
partments in cells harbouring quiescent KM110-R. 
Confluent monolayers of HEL growing on coverslips were 
mock infected (not shown) or infected with 6 PFU/cell of 
KM110-R to establish quiescence. Four days later the cells 
were either mock infected or superinfected with 30 PFU/cell 
of n212 or 10 PFU/cell KOS (not shown) in the presence or 
absence of 400 µg/mL PAA. 9.5 hours later the cells were 
fixed and processed for visualization of ICP4 by indirect 
immunofluorescence. Nuclei were counter-stained with 
Hoescht 33342. Representative fields of cells harbouring 
KM110-R are shown following mock-infection or infection 
with n212 in the presence and absence of PAA.
A B
CD
mock mock
n212 + PAA n212
Efficiency of replication compartment formation Figure 6
Efficiency of replication compartment formation. 
Cells containing or lacking quiescent KM110-R were superin-
fected with n212 or KOS as described in the legend to figure 
5, then examined for viral replication compartments by visu-
alizing the intranuclear distribution of ICP4 (figure 5). Cells 
exhibiting large ICP4 structures that filled an appreciable 
fraction of the nucleus were scored as positive while cells 
displaying diffuse or small punctate ICP4 structures were 
scored as negative. 100–650 cells were scored for each 
treatment group in each experiment. The data presented are 
the average of three independent experiments. Bars repre-
sent the standard deviation.Virology Journal 2005, 2:85 http://www.virologyj.com/content/2/1/85
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The functional inaccessibility of quiescent HSV genomes
documented here is reminiscent of that displayed by
genes located in cellular heterochromatin [61]; however it
is worth emphasizing that previous work has shown that
quiescent HSV genomes lack regularly spaced nucleo-
somes at the tk locus [20], a feature that distinguishes
them both from classical heterochromatin and the latent
HSV genomes present in sensory neurons [62]. Moreover,
HSV infection (and ICP0) does not activate the hetero-
chromatinized endogenous cellular β-globin gene in
present fibroblasts, although transfected (and presumably
euchromatic) copies of this gene are susceptible to activa-
tion by HSV infection [63,64]. These considerations raise
the possibility that HSV genome quiescence involves
novel mechanisms, perhaps related to those that inhibit
HSV transcription in response to type I IFN [51,65].
Indeed, ICP0 is able to overcome the IFN-induced barrier
to HSV transcription [51], in addition to triggering reacti-
vation of quiescent HSV genomes. It therefore seems
likely that further studies of the mode of action of ICP0
may illuminate one or more intranuclear mechanisms of
antiviral defense.
Conclusion
Our results provide strong support for the hypothesis that
quiescent HSV genomes are silenced by a cellular mecha-
nism that renders them globally inaccessible to most
trans-acting factors. The implication is that ICP0 triggers
reactivation from quiescence by overcoming this general-
ized barrier to gene expression and DNA replication. Fur-
ther studies designed to identify the components of this
repression mechanism will clarify how the balance
between host intranuclear repression mechanisms and
viral countermeasures regulates the onset of the HSV lytic
program of gene expression.
Methods
Cells and Virus
Human U2OS osteosarcoma cells, Human Embryonic
Lung (HEL) fibroblasts and African green monkey kidney
(Vero) cells were obtained from the American Type Cul-
ture Collection. E5 [66] and V27 [67] cells were gifts from
N. A. DeLuca and S. Rice respectively. Cells were main-
tained in Dulbecco's Modified Eagle Medium (DMEM)
(Gibco) supplemented with 10% (U2OS and HEL) or 5%
(Vero) fetal bovine serum (FBS), 50 units/ml penicillin
(P) and 5 µg/ml streptomycin (S). E5 and V27 cells were
additionally supplemented with 100 µg/ml G418
(Geneticin®, GIBCO).
KOS 1.1 (a wild-type strain of HSV-1), KOS-G (see below)
and d22lacZ ([68] ICP22-) were grown and titered on
Vero cells. n212 ([6] ICP0-), n212-G, KM110 ([53] VP16/
ICP0- double mutant) and KM110-R were grown and
titered on U20S cells (in the presence of 3 mM HMBA for
KM110). d120 ([58] ICP4-) and d27-1 ([67] ICP27-) were
grown and titered on complementing E5 and V27 cells
respectively.
In experiments where the progeny of superinfected cul-
tures were examined for recovery of the dsRED gene (table
1), the superinfected cells were treated with an acid gly-
cine wash to remove any input superinfecting virus that
had not penetrated the host cells, as follows. 2 hrs post-
superinfection, the growth medium from monolayers
grown in 12 well plates was aspirated. The cells were then
incubated with 1 ml Acid Glycine wash (8 g/L NaCl, 1.8
g/L KCl, 0.1 g/L MgCl2·6H2O, 0.1 g/L CaCl2·6H2O, 7.5 g/
L glycine, pH 3) for 30 seconds. After two washes with 1
ml Phosphate Buffered Saline (PBS: 10 mg/ml NaCl, 0.25
mg/ml KCl, 1.8 mg/ml Na2HPO4, 0.3 mg/ml KH2PO4, pH
7.5), regular growth medium was added.
Construction of recombinant viruses
We modified KOS1.1, n212, and KM110 by inserting
transgenes encoding eGFP (KOS-G, n212-G) or dsRed2
(KM110-R) driven from the human cytomegalovirus
immediate-early promoter into the viral thymidine kinase
(tk) locus in the tk sense orientation. To this end, 1.6 kbp
Ase I-Mlu I fragments bearing the HCMV promoter,
Table 1: Viral progeny recovered from superinfected cells. HEL cells containing or lacking quiescent KM110-R (MOI 6) were 
superinfected on day 4 with either KOS or n212 (MOIs of 10 and 30 respectively). Progeny virus harvested 18 hours later was then 
titrated on U2OS cells in the presence of HMBA (Methods).
Superinfecting virus KM110-R RFP- titre (PFU/mL) RFP+ titre (PFU/mL)
none - 0 N/A
+ 0 1.25 × 103 ± 1.5 × 103
n212 - 3.66 × 107 ± 1.3 × 107 N/A
+1 . 7 9  ×  1 0 7 ± 8.6 × 106 1.00 × 104 ± 6.8 × 103
KOS - 5.52 × 107 ± 2.2 × 107 N/A
+2 . 6 3  ×  1 0 7 ± 3.9 × 106 8.30 × 106 ± 7.4 × 105Virology Journal 2005, 2:85 http://www.virologyj.com/content/2/1/85
Page 11 of 14
(page number not for citation purposes)
DsRed2 or eGFP coding sequence, and SV40 early polya-
denylation signal were excised from pDsRed2-C1(Clon-
tech) or pEGFP-C1 (Clontech) and inserted into SstI site
in the tk coding sequences carried by pTK173 after making
all ends blunt, generating pTK-Red and pTK-Green. The
resulting tk-deficient insertion mutations were then trans-
ferred into the intact viral genomes of KOS1.1, n212, and
KM110 via DNA-mediated marker rescue using standard
methods. Briefly, 350 ng of pTK-Red or pTK-Green
(cleaved with Afl III) was combined with 1–2 µg of total
cellular DNA extracted from cells infected with the target
virus, and the resulting mixture was transfected into U2OS
cells using Fugene (Roche). Recombinants were then iso-
lated from the progeny of the co-transfection by picking
red or green fluorescent plaques. After several rounds of
plaque purification the identity and purity of the recom-
binants was confirmed by Southern blot analysis of the
viral tk, VP16, and ICP0 loci.
Western blot
Samples were subject to electrophoresis through 12% SDS
polyacrylamide gels along with 10 µl pre-stained molecu-
lar weight standards, Low Range (BIO-RAD), then trans-
ferred to a nitrocellulose membrane (Hybond ECL,
Ambersham Pharmacia) using a wet protein transfer
apparatus (Bio-Rad Trans-blot cell). Following the trans-
fer, the membrane was incubated in 10% skim milk TBS-
Tween (25 mM Tris, pH 8, 150 mM NaCl, 0.1% Tween-
20) overnight at 4°C. Monoclonal antibodies to VP16
(LP1, [69] a generous gift from A. Minson) and β-actin
(Sigma Aldrich) were used at dilutions of 1:16,000 and
1:5,000 respectively. The membrane was incubated with
the primary antibody diluted in TBS-Tween/5% skim milk
for 30 min at room temperature then washed three times
for 10 min in TBS-Tween. The membrane was then incu-
bated with secondary antibody, goat anti-mouse IgG-HRP
(BioRad) diluted 1:3,000 in TBS-Tween/5% skim milk, for
30 min at room temperature. After washing three times as
before, the membrane was developed using ECL+plus sys-
tem (Amersham Biosciences) according to the manufac-
ture's instructions. The signal was detected by exposure to
Fuji Super RX X-Ray film.
Southern blot
Total cellular DNA extracted as previously described was
cleaved with a mixture of Bam HI and Nhe I, then sub-
jected to electrophoresis through a 1% agarose gel in Tris-
acetate EDTA (TAE) for 2 hrs at 80 V in TAE buffer. The gel
was then stained with SYBR Gold Nucleic Acid Gel Stain
(Molecular Probes) according the manufacturer's instruc-
tions and quantified by phospho-imager analysis on a
Storm 860 (Molecular Dynamics). The gel was washed
sequentially in the following solutions for 15 min each:
0.25 M HCl, 0.5 M NaOH, 1 M Tris/1.5 M NaCl, and 10 ×
SSC. DNA was transferred to a GeneScreen Plus nylon
membrane (NEN Life Sciences Products) in 10 × SSC. The
membrane was UV-cross linked using Stratalinker 2400
(Stratagene) before being hybridized to a 32P-labelled
1537 nt probe VP16 probe generated by random priming.
The probe fragment was obtained by polymerase chain
reaction using pVP16 KOS [70] as the template and the
primers 5' CGCCGTCGGGCGTCCCACAC 3' and 5'
CGGGGGATGCGGATCCGGTCGCGC 3'. The 32P signal
was detected by exposure to Kodak BioMax MS film at -
80°C.
Flow cytometry
Cells were detached from the growth surface with trypsin,
resuspended in DMEM and transferred to a 5 ml Falcon
tube. Red and green fluorescence was quantified by pass-
ing the cells through a Becton Dickson FACScan and ana-
lyzed using CellQuest Software. HEL cells exhibit
substantial levels of autofluorescence, potentially interfer-
ing with the analysis. However, we found that the intensi-
ties of the red and green autofluorerescent signals emitted
by individual HEL cells are highly correlated (see for
example figure 1) such that cells expressing neither
dsRED2 nor eGFP fall on the diagonal of plots of green
versus red signal intensity. This correlation allows cells
expressing even low levels of dsRED2 to be readily
detected as signals above the control diagonal (shown as
the red dots figure 1). Note that this procedure uses the
green autofluorescent signal emmited by each cell to esti-
mate its autofluorence in the read channel. However, this
procedure cannot be used if the cells also express eGFP
(see figure 3), because the green autofluorescence is
masked by the eGFP fluorescence. Hence, the only a
minority of the RFP+ cells can be detected when the cells
also express GFP (indicated by the purple dots in figure 3).
Detection of viral DNA replication compartments via 
indirect immunofluorescence of ICP4
Monolayers of HEL cells grown on 18 mm coverslips
(Fisher Scientific) in a 12 well plate were fixed by washing
twice with 1 ml PBS and incubating in 400 µl PBS contain-
ing 5% formaldehyde and 2% sucrose for 10 min. This
and subsequent manipulations were at room tempera-
ture. The cells were then permeabilized by washing twice
with 1 ml PBS and incubating in 400 µl PBS containing
0.6% NonidetP-40 and 10% sucrose for 10 min. After
washing twice more with 1 ml PBS/1% FBS, the cells were
incubated with 100 µl primary anti-ICP4 monoclonal
antibody (#1114, Goodwin Institute) diluted 1:1000 in
PBS/1%FBS for 1 hr, and washed six times with PBS/1%
FBS over 15 min. The cells were then incubated in 100 µl
Alexa Fluor® 488 labeled goat anti-mouse IgG (Molecular
Probes) diluted 1:1000 in PBS/1%FBS for 1 hr and
washed six times as before. The cell nuclei were stained by
incubating in 100 µl of 500 ng/ml Hoescht 33342 (Molec-
ular Probes) in PBS solution for 10 min, protected fromVirology Journal 2005, 2:85 http://www.virologyj.com/content/2/1/85
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the light. After washing three times in PBS/1% FBS, the
coverslips were dipped in H2O, and allowed to dry for 15
min, protected from the light. The coverslips were
mounted on slides using 20 µl Vectashield mounting
medium, and secured with clear nail polish. Slides were
examined using a Zeiss LSM 510, 2 photon Laser Scanning
Microscope system with two lasers giving excitation lines
at 488 nm (for Alexa Fluor 488) and 780 nm (for Hoescht
stain), and using a 40× oil immersion objective lens.
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